Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0074 | 0.1247 | 1 |
Mycobacterium ulcerans | isocitrate lyase AceAb | 0.0507 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0454 | 0.3223 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0039 | 0.0531 | 0.3879 |
Mycobacterium tuberculosis | Isocitrate lyase Icl (isocitrase) (isocitratase) | 0.0507 | 1 | 1 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0043 | 0.0616 | 0.4606 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) | 0.0507 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0923 | 0.7227 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0046 | 0.0681 | 0.516 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) | 0.0507 | 1 | 1 |
Trypanosoma brucei | unspecified product | 0.0039 | 0.0531 | 0.3879 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0074 | 0.1247 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0024 | 0.0227 | 0.0151 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0074 | 0.1247 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0074 | 0.1247 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0074 | 0.1247 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0125 | 0.0408 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0125 | 0.0408 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Mycobacterium ulcerans | isocitrate lyase Icl | 0.0507 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0035 | 0.0454 | 0.3223 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0046 | 0.0681 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0565 | 0.4172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Brugia malayi | polk-prov protein | 0.0035 | 0.0454 | 0.3223 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0043 | 0.0616 | 0.4606 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0074 | 0.1247 | 1 |
Brugia malayi | hypothetical protein | 0.004 | 0.0565 | 0.4172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Leishmania major | DNA polymerase kappa, putative | 0.0024 | 0.0227 | 0.128 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0046 | 0.0681 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0565 | 0.4172 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0565 | 0.4172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0074 | 0.1247 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0074 | 0.1247 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0125 | 0.0408 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0024 | 0.0227 | 0.128 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0046 | 0.0681 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0024 | 0.0227 | 0.128 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.0565 | 0.4172 |
Echinococcus multilocularis | dna polymerase kappa | 0.0046 | 0.0681 | 0.516 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0074 | 0.1247 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Giardia lamblia | DINP protein human, muc B family | 0.0024 | 0.0227 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0035 | 0.0454 | 0.3223 |
Echinococcus granulosus | dna polymerase kappa | 0.0046 | 0.0681 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0565 | 0.4172 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.0565 | 0.4172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0046 | 0.0681 | 0.516 |
Toxoplasma gondii | BRCA1 C Terminus (BRCT) domain-containing protein | 0.0012 | 0 | 0.5 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0074 | 0.1247 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.0565 | 0.4172 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0565 | 0.4172 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 0.0014 mg kg-1 | Analgesic activity (ED50) using tail-flick assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.0014 mg kg-1 | Analgesic activity (ED50) using tail-pinch assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.0014 mg kg-1 | Analgesic activity (ED50) using tail-flick assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.0014 mg kg-1 | Analgesic activity (ED50) using tail-pinch assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.0018 mg kg-1 | Analgesic activity (ED50) measured using HCl writhing assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.0018 mg kg-1 | Analgesic activity (ED50) measured using HCl writhing assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.1 mg kg-1 | Analgesic activity (ED50) using inclined screen assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 0.1 mg kg-1 | Analgesic activity (ED50) using inclined screen assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 56 mg kg-1 | Analgesic activity (ED50) measured using HCl writhing assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | = 56 mg kg-1 | Analgesic activity (ED50) measured using HCl writhing assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Analgesic activity (ED50) using tail-flick assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Analgesic activity (ED50) using tail-pinch assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Analgesic activity (ED50) using inclined screen assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Blockade of morphine-induced elevation of tail-flick latency | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Analgesic activity (ED50) using tail-flick assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Analgesic activity (ED50) using tail-pinch assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Analgesic activity (ED50) using inclined screen assay in mice | ChEMBL. | 7265128 |
ED50 (functional) | > 100 mg kg-1 | Blockade of morphine-induced elevation of tail-flick latency | ChEMBL. | 7265128 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.